SUMMARY A histopathological index of contractility failure, which was reported to be accurate for the diagnosis of idiopathic dilated or congestive cardiomyopathy in Japan, was used to assess endomyocardial biopsy specimens from 41 Dutch patients with suspected dilated cardiomyopathy. The calculated index had a sensitivity of 62 5% and a specificity of 68% for idiopathic dilated or congestive cardiomyopathy. These disappointing results indicate that the histopathological index of contractility failure does not reliably distinguish between idiopathic dilated cardiomyopathy and other diseases that cause congestive heart failure.
It is a matter of debate whether or not endomyocardial biopsy specimens should be used for the diagnosis and management of patients with idiopathic dilated (congestive) cardiomopathy.1 3 The criteria set by the WHO/ISFC task force define the term "dilated cardiomyopathy" as a heart muscle disease of obscure origin with dilation of the ventricles. 4 Decreased myocardial contractility is the prime mechanical disorder. 5 The histopathological findings, such as myocyte hypertrophy, degeneration, interstitial fibrosis, and endocardial proliferative changes, are in themselves non-specific. 69 The major contribution of an endomyocardial biopsy specimen, therefore, is to rule out other conditions that can cause congestive heart failure, such as idiopathic myocarditis.10 The existence of a relation between the features of endomyocardial biopsy specimens and prognosis is also controversial. Some workers found that prognosis was poor when myocardial fibrosis was widespread,7 1 but others did not find such a clear correlation *Present address: Department of Paediatrics, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki-shi, Aomori-Ken, 036 Japan. Requests 160 five patients with primary arrhythmias and the two patients with valvar heart disease. Figure 4 shows the histopathological contractility failure index and the corresponding clinical diagnosis for all patients. According to Sekiguchi and coworkers a high index score is diagnostic for dilated cardiomyopathy. They use a mean (SD) value of 3-5 (1 4) as the indicator for the disease. 19 In the present study, therefore, an index score of > 3 is regarded as positive histological evidence of dilated cardiomyopathy.
The sensitivity and specificity of the index were as follows: The diagnosis idiopathic dilated or congestive cardiomyopathy is difficult because it is based mainly on the exclusion of known causes of heart failure rather than on positive criteria. It is likely that the disease has a multifactorial origin with a final common pathway characterised by decreased myocardial contractility. From this it is understandable that the histopathology in the later stages of the disease will be non-specific and, from the point of view of diagnosis, not very helpful. Baandrup et al did not find a significant correlation between the histological features and the clinical diagnosis in a series of 361 endomyocardial biopsy specimens from patients with suspected cardiomyopathy. 13 Moreover, they were unable to confirm the congestive nature of the underlying heart disease on the basis of the biopsy specimens alone and concluded that biopsy specimens did not indicate the prognosis. Moreover, in a retrospective study, they found no relation between ultrastructural findings and prognosis.20 When Breithardt and co-workers used a scoring system that resembled the one used by Baandrup et al they too concluded that the results of long term follow up could not be accurately established from biopsy specimens.12 On the other hand, myocyte degeneration appeared to be a prognostically important factor in patients with a history of less than two years. More recently, Rose and Beck examined 76 endomyocardial biopsy specimens from patients with the clinical diagnosis of dilated cardiomyopathy and 54 necropsy specimens from Yonesaka, Becker patients with this disease.2" They found fibrosis in only 28% of the endomyocardial biopsy specimens and in 50% of the sections obtained at necropsy. Moreover, they found remarkably little myocytolysis-none in the endomyocardial biopsy specimens and only 9% in the necropsy series. These workers also concluded that the clinical evaluation of cardiac dysfunction correlated poorly with the morphology of the myocardial tissue. The findings of Rose and Beck,2" in particular, are in striking contrast with the observations made by Sekiguchi et al, who showed 100% fibrosis both in the endomyocardial biopsy specimens and in the necropsy specimens and a much higher frequency of degeneration, including myocytolysis. In fact, Sekiguchi et al emphasised that a semiquantitative assessment of the endomyocardial biopsy specimens predicted the outcome in patients with dilated cardiomyopathy. '7 -19 Why do workers in different parts of the world come to such divergent conclusions? We followed Sekiguchi's method as closely as possible. This was not easy because the precise criteria on how to apply the grading system from 0 to 3 for each of the key items-that is degeneration and lysis of myocytes, interstitial fibrosis, and fragmentation of muscle bundles-are not clearly stated. Moreover, identification of the histopathological features promoted by the Japanese workers is highly subjective. Another important criticism is that the changes may represent various non-specific responses to injury, such as ischaemia. For instance, the degenerative changes that they assess are for the most part myofibrillar degeneration as described by Reichenbach and Benditt22 (fig la) . Also vacuolar degeneration (fig lb) is highly suggestive of subendocardial ischaemia as described by Geer et al. 23 The changes regarded as typical of fragmentation of myocytes may be partly the result of orientation of myocytes out of the plane of section and fibrosis. In the present study, however, these changes were categorised as "fragmentation". Despite our reservations about the histological interpretation of these features we followed the Japanese criteria as closely as possible to ensure that the two studies were comparable.
We found that histological assessment did not allow a clear and unambiguous differentiation of the various clinical subgroups or of individual patients. Nevertheless, the histopathological index was much higher in patients with dilated cardiomyopathy (3-3) than in those with hypertrophic cardiomyopathy (1-2). In patients with arrhythmia, valvar heart disease, ischaemic cardiomyopathy, and heart disease secondary to long lasting hypertension, however, the histopathological contractility failure index was in group.bmj.com on June 25, 2017 -Published by http://heart.bmj.com/ Downloaded from Dilated cardiomyopathy: diagnostic accuracy of endomyocardial biopsy 161 the range of that found in dilated cardiomyopathy. Moreover, when an index score of three was taken to indicate the diagnosis of dilated cardiomyopathy the sensitivity was 62-5% and the specificity was 68%.
We found that the histopathological contractility failure index was not a reliable tool in diagnosing dilated cardiomyopathy. The results suggest that the index reflects cardiac muscle damage that is not necessarily specific to idiopathic dilated cardiomyopathy. This conclusion accords with the nonspecific histological criteria of the index and the current hypothesis that dilated cardiomyopathy is not an entity in the strict sense but rather a multifactorial disease with a final common pathway leading to heart failure.
